TY - JOUR
T1 - Azithromycin susceptibility testing of Salmonella enterica serovar Typhi: Impact on management of enteric fever: Impact on management of enteric fever
AU - Skittrall, Jordan P.
AU - Levy, David
AU - Obichukwu, Christian
AU - Gentle, Amy
AU - Chattaway, Marie A.
AU - Hayns, David
AU - Etheridge, Clare
AU - Parry, Christopher
AU - Wong, Vanessa
AU - Whitehorn, James
PY - 2021/4/1
Y1 - 2021/4/1
N2 - Background: Drug-resistant enteric fever is increasingly common in the Indian subcontinent. Correctly determining azithromycin resistance matters where drug-resistant enteric fever is common and oral therapy necessary. Case report: In two patients returning from Pakistan to the UK with cephalosporin-resistant Salmonella enterica serovar Typhi, gradient strip testing erroneously indicated azithromycin resistance; the errors were detected by repeat testing and confirmed by whole genome sequencing. Results: Both patients were treated with meropenem and, when revised susceptibility results were known, with azithromycin, allowing a switch to oral therapy. Conclusion: As cephalosporin resistance becomes more common, azithromycin will be key for treating enteric fever and optimizing practice in susceptibility testing will be crucial. Practitioners should be aware of key steps to minimize error in azithromycin susceptibility testing, and should be alert for possible errors when reported azithromycin resistance is discordant with known prevalence of resistance.
AB - Background: Drug-resistant enteric fever is increasingly common in the Indian subcontinent. Correctly determining azithromycin resistance matters where drug-resistant enteric fever is common and oral therapy necessary. Case report: In two patients returning from Pakistan to the UK with cephalosporin-resistant Salmonella enterica serovar Typhi, gradient strip testing erroneously indicated azithromycin resistance; the errors were detected by repeat testing and confirmed by whole genome sequencing. Results: Both patients were treated with meropenem and, when revised susceptibility results were known, with azithromycin, allowing a switch to oral therapy. Conclusion: As cephalosporin resistance becomes more common, azithromycin will be key for treating enteric fever and optimizing practice in susceptibility testing will be crucial. Practitioners should be aware of key steps to minimize error in azithromycin susceptibility testing, and should be alert for possible errors when reported azithromycin resistance is discordant with known prevalence of resistance.
KW - Azithromycin
KW - Drug Resistance, Microbial
KW - Microbial Sensitivity Tests
KW - Salmonella Infections
KW - Typhoid Fever
U2 - 10.1016/j.clinpr.2021.100069
DO - 10.1016/j.clinpr.2021.100069
M3 - Article
SN - 2590-1702
VL - 10
JO - Clinical Infection in Practice
JF - Clinical Infection in Practice
M1 - 100069
ER -